Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib.

Saved in:
Bibliographic Details
Title: Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib.
Authors: Robinson ND; Yale University School of Medicine, New Haven, CT., Canavan ME; Yale University School of Medicine, New Haven, CT., Zhan PL; Yale University School of Medicine, New Haven, CT., Udelsman BV; Keck School of Medicine of University of Southern California, Los Angeles, CA., Pathak R; Enloe Hematology Oncology, Chico, CA., Boffa DJ; Yale University School of Medicine, New Haven, CT., Goldberg SB; Yale University School of Medicine, New Haven, CT. Electronic address: sarah.goldberg@yale.edu.
Source: Clinical lung cancer [Clin Lung Cancer] 2025 Jan; Vol. 26 (1), pp. 9-17.e3. Date of Electronic Publication: 2024 Sep 23.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0690
DOI:10.1016/j.cllc.2024.09.006